OR WAIT null SECS
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
US-based SP Industries acquired the sterile filling line assets of Spain-based i-Dositecno.
SP Industries (SP), a PA-based designer and manufacturer of laboratory equipment, pharmaceutical fill/finish manufacturing solutions, laboratory supplies, and glassware, announced in an Oct. 28, 2019 press release that it acquired the assets of privately held i-Dositecno, a global provider of sterile filling lines for pharmaceutical, cosmetic, and ophthalmic applications located in Mataro, Spain.
“i-Dositecno has a well-earned reputation for producing high quality, fill/finish equipment complemented by strong software engineering capabilities and innovative servicing and support,” stated SP CEO Brian Larkin in the release. He said that the i-Dositecno’s portfolio, engineering expertise, and liquid filling capabilities complement SP’s freeze dryers and aseptic vial processing lines.
“As biological drug development and treatment protocols have become more specialized, we expect short-run aseptic liquid filling to continue to drive pharmaceutical growth,” said Larkin in the release. “With the addition of i-Dositecno to our SP brand, we now join a very select group of manufacturers with the capability to provide full lines. And, while SP has traditionally had a stronger equipment footprint in the United States, i-Dositecno’s efforts and success have primarily been within Europe and Asia. These relationships, as well as the addition of a Spain location to our current UK manufacturing within Europe, provide significant opportunity to better serve the worldwide market. Key manufacturing, engineering, sales, and service personnel from i-Dositecno have joined the SP team to assure continuity in operations and service. Oriol Casoliva, founder and past CEO of i-Dositecno, will join SP’s Executive Leadership Team, and we look forward to benefiting from his vision and depth of knowledge in maximizing i-Dositecno and SP’s performance within the aseptic pharmaceutical manufacturing space.”
Source: SP Industries